[New aspects of therapy with blood and blood components].
For diminishing transfusion risks and for ethical and economical reasons a rational hemotherapy is indispensable. The "Berner model" referred to here contains an acceptable explanation. It is evident that the overwhelming part of surgical interventions is accomplished by using erythrocyte concentrates. Therefore, fresh whole blood and fresh frozen plasma are better available. Coagulational active plasma fractions have unchanged indications for a rational substitution of coagulation factors. New indications for some blood components are described.
D001779:Blood Coagulation Factors / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D001803:Blood Transfusion / Q000379:methods*; D001810:Blood Volume; D017707:Erythrocyte Transfusion; D006098:Granulocytes / Q000637:transplantation; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D010949:Plasma; D017713:Platelet Transfusion; D011183:Postoperative Complications / Q000097:blood; D012306:Risk; D012709:Serum Albumin / Q000032:analysis
D001779:Blood Coagulation Factors; D001798:Blood Proteins; D012709:Serum Albumin
Neue Aspekte der Therapie mit Blut und Blutkomponenten.